Vanda Pharmaceuticals
VNDA
VNDA
160 hedge funds and large institutions have $1.2B invested in Vanda Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
28% more capital invested
Capital invested by funds: $934M → $1.2B (+$264M)
19% more funds holding
Funds holding: 135 → 160 (+25)
5.6% more ownership
Funds ownership: 94.08% → 99.67% (+5.6%)
Holders
160
Holding in Top 10
4
Calls
$4.21M
Puts
$1.46M
Top Buyers
| 1 | +$89.1M | |
| 2 | +$40.5M | |
| 3 | +$14.4M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$12M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$10.1M |
Top Sellers
| 1 | -$54.4M | |
| 2 | -$30.4M | |
| 3 | -$27.3M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$18.2M |
| 5 |
Morgan Stanley
New York
|
-$14.4M |